Intramuscular lipid metabolism, insulin action, and obesity

IUBMB Life

Volumn 61, Issue 1, 2009, Pages 47-55

  Consitt, Leslie A ^a   Bell, Jill A ^b   Houmard, Joseph A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

IMCL; Insulin action; Lipid metabolism; Obesity; Skeletal muscle

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; ACETYL COENZYME A; ACYL COENZYME A; ADENOSINE TRIPHOSPHATE; CARNITINE PALMITOYLTRANSFERASE I; CD36 ANTIGEN; CERAMIDE; CITRATE SYNTHASE; CYTOCHROME C OXIDASE; DIACYLGLYCEROL; FATTY ACID BINDING PROTEIN; FATTY ACID TRANSPORTER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; LONG CHAIN FATTY ACYL COENZYME A; MITOCHONDRIAL DNA; PALMITIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG;

CELL MEMBRANE; CITRIC ACID CYCLE; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPID OXIDATION; LIPID STORAGE; METABOLISM; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MUSCLE CELL; MUSCLE METABOLISM; MYOTUBE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RESPIRATORY CHAIN; RESPIRATORY QUOTIENT; REVIEW; SKELETAL MUSCLE; BIOLOGICAL MODEL; PHYSIOLOGY; SIGNAL TRANSDUCTION;

HUMANS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; MITOCHONDRIA; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; OBESITY; SIGNAL TRANSDUCTION;

EID: 61849185113     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.142     Document Type: Review

References (99)

1. Flegal, K. M., Carroll, M. D., Ogden, C. L., and Johnson, C. L. (2002) Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288, 1723-1727.
2. Amos, A. F., McCarty, D. J., and Zimmet, P. (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet. Med. 14 (Suppl. 5), S1-S85.
3. DeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., and Felber, J. P. (1981) The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30, 1000-1007.
4. Dagenais, G. R., Tancredi, R. G., and Zierler, K. L. (1976) Free fatty acid oxidation by forearm muscle at rest, and evidence for an intramuscular lipid pool in the human forearm. J. Clin. Invest. 58, 421-431.
5. Kelley, D. E., Mokan, M., Simoneau, J. A., and Mandarino, L. J. (1993) Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J. Clin. Invest. 92, 91-98.
6. Belfort, R., Mandarino, L., Kashyap, S., Wirfel, K., Pratipanawatr, T., Berria, R., Defronzo, R. A., and Cusi, K. (2005) Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54, 1640-1648.
7. Oakes, N. D., Cooney, G. J., Camilleri, S., Chisholm, D. J., and Kraegen, E. W. (1997) Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes 46, 1768-1774.
8. Boden, G., Chen, X., Ruiz, J., White, J. V., and Rossetti, L. (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J. Clin. Invest. 93, 2438-2446.
9. Itani, S. I., Ruderman, N. B., Schmieder, F., and Boden, G. (2002) Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. Diabetes 51, 2005-2011.
10. Campbell, J., Martucci, A. D., and Green, G. R. (1964) Plasma albumin as an acceptor of free fatty acids. Biochem. J. 93, 183-189.
11. Abumrad, N., Harmon, C., and Ibrahimi, A. (1998) Membrane transport of long-chain fatty acids: evidence for a facilitated process. J. Lipid. Res. 39, 2309-2318.
12. Hamilton, J. A. (1998) Fatty acid transport: difficult or easy? J. Lipid. Res. 39, 467-481.
13. Bonen, A., Luiken, J. J., Arumugam, Y., Glatz, J. F., and Tandon, N. N. (2000) Acute regulation of fatty acid uptake involves the cellular redistribution of fatty acid translocase. J. Biol. Chem. 275, 14501-14508.
14. Chabowski, A., Coort, S. L., Calles-Escandon, J., Tandon, N. N., Glatz, J. F., Luiken, J. J., and Bonen, A. (2004) Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm. Am. J. Physiol. Endocrinol. Metab. 287, E781-E789.
15. Coburn, C. T., Knapp, F. F. Jr., Febbraio, M., Beets, A. L., Silverstein, R. L., and Abumrad, N. A. (2000) Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J. Biol. Chem. 275, 32523-32529.
16. Schwieterman, W., Sorrentino, D., Potter, B. J., Rand, J., Kiang, C. L., Stump, D., and Berk, P. D. (1988) Uptake of oleate by isolated rat adipocytes is mediated by a 40-kDa plasma membrane fatty acid binding protein closely related to that in liver and gut. Proc. Natl. Acad. Sci. USA 85, 359-363.
17. Gimeno, R. E., Ortegon, A. M., Patel, S., Punreddy, S., Ge, P., Sun, Y., Lodish, H. F., and Stahl, A. (2003) Characterization of a heart-specific fatty acid transport protein. J. Biol. Chem. 278, 16039-16044.
18. Schaffer, J. E., and Lodish, H. F. (1994) Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein. Cell 79, 427-436.
19. Hirsch, D., Stahl, A., and Lodish, H. F. (1998) A family of fatty acid transporters conserved from mycobacterium to man. Proc. Natl. Acad. Sci. USA 95, 8625-8629.
20. Febbraio, M., Hajjar, D. P., and Silverstein, R. L. (2001) CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108, 785-791.
21. Febbraio, M., Abumrad, N. A., Hajjar, D. P., Sharma, K., Cheng, W., Pearce, S. F., and Silverstein, R. L. (1999) A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 274, 19055-19062.
22. Luiken, J. J., Koonen, D. P., Willems, J., Zorzano, A., Becker, C., Fischer, Y., Tandon, N. N., Van Der Vusse, G. J., Bonen, A., and Glatz, J. F. (2002) Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. Diabetes 51, 3113-3119.
23. Luiken, J. J., Coort, S. L., Willems, J., Coumans, W. A., Bonen, A., van der Vusse, G. J., and Glatz, J. F. (2003) Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 52, 1627-1634.
24. Clarke, D. C., Miskovic, D., Han, X. X., Calles-Escandon, J., Glatz, J. F., Luiken, J. J., Heikkila, J. J., and Bonen, A. (2004) Overexpression of membrane-associated fatty acid binding protein (FABPpm) in vivo increases fatty acid sarcolemmal transport and metabolism. Physiol. Genomics 17, 31-37.
25. Wu, Q., Ortegon, A. M., Tsang, B., Doege, H., Feingold, K. R., and Stahl, A. (2006) FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity. Mol. Cell. Biol. 26, 3455-3467.
26. Nickerson, J., and Bonen, A. (2005) Defining a role for skeletal muscle fatty acid transport proteins. In 2nd Northern Lights Conference. Canadian Federation of Biological Societies. p. F47, Guelph, Ontario, Canada.
27. Jeukendrup, A. E. (2002) Regulation of fat metabolism in skeletal muscle. Ann. NY Acad. Sci. 967, 217-235.
28. Kiens, B. (2006) Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol. Rev. 86, 205-243.
29. Bruce, C. R., Brolin, C., Turner, N., Cleasby, M. E., van der Leij, F. R., Cooney, G. J., and Kraegen, E. W. (2007) Overexpression of carnitine palmitoyltransferase I in skeletal muscle in vivo increases fatty acid oxidation and reduces triacylglycerol esterification. Am. J. Physiol. Endocrinol. Metab. 292, E1231-E1237.
30. Kiens, B. (1997) Effect of endurance training on fatty acid metabolism: local adaptations. Med. Sci. Sports Exerc. 29, 640-645.
31. Turcotte, L. P., Srivastava, A. K., and Chiasson, J. L. (1997) Fasting increases plasma membrane fatty acid-binding protein (FABP(PM)) in red skeletal muscle. Mol. Cell. Biochem. 166, 153-158.
32. Roepstorff, C., Helge, J. W., Vistisen, B., and Kiens, B. (2004) Studies of plasma membrane fatty acid-binding protein and other lipid-binding proteins in human skeletal muscle. Proc. Nutr. Soc. 63, 239-244.
33. Bruce, C. R., Anderson, M. J., Carey, A. L., Newman, D. G., Bonen, A., Kriketos, A. D., Cooney, G. J., and Hawley, J. A. (2003) Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status. J. Clin. Endocrinol. Metab. 88, 5444-5451.
34. Simoneau, J. A., Veerkamp, J. H., Turcotte, L. P., and Kelley, D. E. (1999) Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J. 13, 2051-2060.
35. Bonen, A., Parolin, M. L., Steinberg, G. R., Calles-Escandon, J., Tandon, N. N., Glatz, J. F., Luiken, J. J., Heigenhauser, G. J., and Dyck, D. J. (2004) Triacylglycerol accumulation in human obesity and type 2 diabetes is associated with increased rates of skeletal muscle fatty acid transport and increased sarcolemmal FAT/CD36. FASEB J. 18, 1144-1146.
36. Kim, J. Y., Hickner, R. C., Cortright, R. L., Dohm, G. L., and Houmard, J. A. (2000) Lipid oxidation is reduced in obese human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 279, E1039-E1044.
37. Simoneau, J. A., and Kelley, D. E. (1997) Altered glycolytic and oxidative capacities of skeletal muscle contribute to insulin resistance in NIDDM. J. Appl. Physiol. 83, 166-171.
38. Perdomo, G., Commerford, S. R., Richard, A. M., Adams, S. H., Corkey, B. E., O'Doherty, R. M., and Brown, N. F. (2004) Increased beta-oxidation in muscle cells enhances insulin-stimulated glucose metabolism and protects against fatty acid-induced insulin resistance despite intramyocellular lipid accumulation. J. Biol. Chem. 279, 27177-27186.
39. Ritov, V. B., Menshikova, E. V., He, J., Ferrell, R. E., Goodpaster, B. H., and Kelley, D. E. (2005) Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54, 8-14.
40. Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R., Newgard, C. B., Lopaschuk, G. D., and Muoio, D. M. (2008) Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7, 45-56.
41. Kelley, D. E., He, J., Menshikova, E. V., and Ritov, V. B. (2002) Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944-2950.
42. Marra, M., Scalfi, L., Covino, A., Esposito-Del Puente, A., and Contaldo, F. (1998) Fasting respiratory quotient as a predictor of weight changes in non-obese women. Int. J. Obes. Relat. Metab. Disord. 22, 601-603.
43. Zurlo, F., Lillioja, S., Esposito-Del Puente, A., Nyomba, B. L., Raz, I., Saad, M. F., Swinburn, B. A., Knowler, W. C., Bogardus, C., and Ravussin, E. (1990) Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am. J. Physiol. 259, E650-E657.
44. Kelley, D. E., Goodpaster, B., Wing, R. R., and Simoneau, J. A. (1999) Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am. J. Physiol. 277, E1130-E1141.
45. Hulver, M. W., Berggren, J. R., Cortright, R. N., Dudek, R. W., Thompson, R. P., Pories, W. J., MacDonald, K. G., Cline, G. W., Shulman, G. I., Dohm, G. L., and Houmard, J. A. (2003) Skeletal muscle lipid metabolism with obesity. Am. J. Physiol. Endocrinol. Metab. 284, E741-E747.
46. Essen, B., Jansson, E., Henriksson, J., Taylor, A. W., and Saltin, B. (1975) Metabolic characteristics of fibre types in human skeletal muscle. Acta Physiol. Scand. 95, 153-165.
47. Hickey, M. S., Carey, J. O., Azevedo, J. L., Houmard, J. A., Pories, W. J., Israel, R. G., and Dohm, G. L. (1995) Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am. J. Physiol. 268, E453-E457.
48. Tanner, C. J., Barakat, H. A., Dohm, G. L., Pories, W. J., MacDonald, K. G., Cunningham, P. R., Swanson, M. S., and Houmard, J. A. (2002) Muscle fiber type is associated with obesity and weight loss. Am. J. Physiol. Endocrinol. Metab. 282, E1191-E1196.
49. Gray, R. E., Tanner, C. J., Pories, W. J., MacDonald, K. G., and Houmard, J. A. (2003) Effect of weight loss on muscle lipid content in morbidly obese subjects. Am. J. Physiol. Endocrinol. Metab. 284, E726-E732.
50. Berggren, J. R., Boyle, K. E., Chapman, W. H., and Houmard, J. A. (2008) Skeletal muscle lipid oxidation and obesity: influence of weight loss and exercise. Am. J. Physiol. Endocrinol. Metab. 294, E726-E732.
51. Berggren, J. R., Tanner, C. J., and Houmard, J. A. (2007) Primary cell cultures in the study of human muscle metabolism. Exerc. Sport Sci. Rev. 35, 56-61.
52. Hulver, M. W., Berggren, J. R., Carper, M. J., Miyazaki, M., Ntambi, J. M., Hoffman, E. P., Thyfault, J. P., Stevens, R., Dohm, G. L., Houmard, J. A., and Muoio, D. M. (2005) Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab. 2, 251-261.
53. Guesbeck, N. R., Hickey, M. S., MacDonald, K. G., Pories, W. J., Harper, I., Ravussin, E., Dohm, G. L., and Houmard, J. A. (2001) Substrate utilization during exercise in formerly morbidly obese women. J. Appl. Physiol. 90, 1007-1012.
54. Thyfault, J. P., Kraus, R. M., Hickner, R. C., Howell, A. W., Wolfe, R. R., and Dohm, G. L. (2004) Impaired plasma fatty acid oxidation in extremely obese women. Am. J. Physiol. Endocrinol. Metab. 287, E1076-1081.
55. Krssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Roden, M., and Shulman, G. I. (1999) Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42, 113-116.
56. Dobbins, R. L., Szczepaniak, L. S., Bentley, B., Esser, V., Myhill, J., and McGarry, J. D. (2001) Prolonged inhibition of muscle carnitine palmitoyltransferase-1 promotes intramyocellular lipid accumulation and insulin resistance in rats. Diabetes 50, 123-130.
57. Jacob, S., Machann, J., Rett, K., Brechtel, K., Volk, A., Renn, W., Maerker, E., Matthaei, S., Schick, F., Claussen, C. D., and Haring, H. U. (1999) Association of increased intramyocellular lipid content with insulin resistance in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes 48, 1113-1119.
58. Jazet, I. M., Schaart, G., Gastaldelli, A., Ferrannini, E., Hesselink, M. K., Schrauwen, P., Romijn, J. A., Maassen, J. A., Pijl, H., Ouwens, D. M., and Meinders, A. E. (2008) Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients. Diabetologia 51, 309-319.
59. Lara-Castro, C., Newcomer, B. R., Rowell, J., Wallace, P., Shaughnessy, S. M., Munoz, A. J., Shiflett, A. M., Rigsby, D. Y., Lawrence, J. C., Bohning, D. E., Buchthal, S., and Garvey, W. T. (2008) Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects. Metabolism 57, 1-8.
60. Greco, A. V., Mingrone, G., Giancaterini, A., Manco, M., Morroni, M., Cinti, S., Granzotto, M., Vettor, R., Camastra, S., and Ferrannini, E. (2002) Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51, 144-151.
61. Goodpaster, B. H., He, J., Watkins, S., and Kelley, D. E. (2001) Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J. Clin. Endocrinol. Metab. 86, 5755-5761.
62. Schenk, S., and Horowitz, J. F. (2007) Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. J. Clin. Invest. 117, 1690-1698.
63. Bell, R. M., and Coleman, R. A. (1980) Enzymes of glycerolipid synthesis in eukaryotes. Annu. Rev. Biochem. 49, 459-487.
64. Lehner, R. and Kuksis, A. (1996) Biosynthesis of triacylglycerols. Prog. Lipid. Res. 35, 169-201.
65. Bagnato, C., and Igal, R. A. (2003) Overexpression of diacylglycerol acyltransferase-1 reduces phospholipid synthesis, proliferation, and invasiveness in simian virus 40-transformed human lung fibroblasts. J. Biol. Chem. 278, 52203-52211.
66. Liu, L., Zhang, Y., Chen, N., Shi, X., Tsang, B., and Yu, Y. H. (2007) Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J. Clin. Invest. 117, 1679-1689.
67. Pinnamaneni, S. K., Southgate, R. J., Febbraio, M. A., and Watt, M. J. (2006) Stearoyl CoA desaturase 1 is elevated in obesity but protects against fatty acid-induced skeletal muscle insulin resistance in vitro. Diabetologia 49, 3027-3037.
68. Listenberger, L. L., Han, X., Lewis, S. E., Cases, S., Farese, R. V. Jr., Ory, D. S., and Schaffer, J. E. (2003) Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. USA 100, 3077-3082.
69. Folli, F., Saad, M. J., Backer, J. M., and Kahn, C. R. (1992) Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. J. Biol. Chem. 267, 22171-22177.
70. Chang, L., Chiang, S. H., and Saltiel, A. R. (2004) Insulin signaling and the regulation of glucose transport. Mol. Med. 10, 65-71.
71. Frosig, C., Rose, A. J., Treebak, J. T., Kiens, B., Richter, E. A., and Wojtaszewski, J. F. (2007) Effects of endurance exercise training on insulin signaling in human skeletal muscle: interactions at the level of phosphatidylinositol 3-kinase, Akt, and AS160. Diabetes 56, 2093-2102.
72. Kramer, H. F., Witczak, C. A., Taylor, E. B., Fujii, N., Hirshman, M. F., and Goodyear, L. J. (2006) AS160 regulates insulin- and contraction-stimulated glucose uptake in mouse skeletal muscle. J. Biol. Chem. 281, 31478-31485.
73. Itani, S. I., Zhou, Q., Pories, W. J., MacDonald, K. G., and Dohm, G. L. (2000) Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes 49, 1353-1358. (Pubitemid 30624237)
74. Newton, A. C. (1995) Protein kinase C: structure, function, and regulation. J. Biol. Chem. 270, 28495-28498.
75. Cortright, R. N., Azevedo, J. L. Jr., Zhou, Q., Sinha, M., Pories, W. J., Itani, S. I., and Dohm, G. L. (2000) Protein kinase C modulates insulin action in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 278, E553-E562.
76. Schmitz-Peiffer, C. (2002) Protein kinase C and lipid-induced insulin resistance in skeletal muscle. Ann. NY Acad. Sci. 967, 146-157.
77. Ellis, B. A., Poynten, A., Lowy, A. J., Furler, S. M., Chisholm, D. J., Kraegen, E. W., and Cooney, G. J. (2000) Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle. Am. J. Physiol. Endocrinol. Metab. 279, E554-E560.
78. Dohm, G. L., Tapscott, E. B., Pories, W. J., Dabbs, D. J., Flickinger, E. G., Meelheim, D., Fushiki, T., Atkinson, S. M., Elton, C. W., and Caro, J. F. (1988) An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J. Clin. Invest. 82, 486-494.
79. Chalkley, S. M., Hettiarachchi, M., Chisholm, D. J., and Kraegen, E. W. (1998) Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. Metabolism 47, 1121-1126.
80. Bajaj, M., Suraamornkul, S., Romanelli, A., Cline, G. W., Mandarino, L. J., Shulman, G. I., and DeFronzo, R. A. (2005) Effect of a sustained reduction in plasma free fatty acid concentration on intramuscular long-chain fatty Acyl-CoAs and insulin action in type 2 diabetic patients. Diabetes 54, 3148-3153.
81. Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., Atcheson, B., White, M. F., Kraegen, E. W., and Shulman, G. I. (2002) Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277, 50230-50236.
82. Hannun, Y. A., and Obeid, L. M. (2002) The ceramide-centric universe of lipid-mediated cell regulation: stress encounters of the lipid kind. J. Biol. Chem. 277, 25847-25850.
83. Merrill, A. H. Jr., and Jones, D. D. (1990) An update of the enzymology and regulation of sphingomyelin metabolism. Biochim. Biophys. Acta 1044, 1-12.
84. Adams, J. M. II, Pratipanawatr, T., Berria, R., Wang, E., DeFronzo, R. A., Sullards, M. C., and Mandarino, L. J. (2004) Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 53, 25-31.
85. Turinsky, J., O'Sullivan, D. M., and Bayly, B. P. (1990) 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J. Biol. Chem. 265, 16880-16885.
86. Straczkowski, M., Kowalska, I., Nikolajuk, A., Dzienis-Straczkowska, S., Kinalska, I., Baranowski, M., Zendzian-Piotrowska, M., Brzezinska, Z., and Gorski, J. (2004) Relationship between insulin sensitivity and sphingomyelin signaling pathway in human skeletal muscle. Diabetes 53, 1215-1221.
87. Straczkowski, M., Kowalska, I., Baranowski, M., Nikolajuk, A., Otziomek, E., Zabielski, P., Adamska, A., Blachnio, A., Gorski, J., and Gorska, M. (2007) Increased skeletal muscle ceramide level in men at risk of developing type 2 diabetes. Diabetologia 50, 2366-2373.
88. Serlie, M. J., Meijer, A. J., Groener, J. E., Duran, M., Endert, E., Fliers, E., Aerts, J. M., and Sauerwein, H. P. (2007) Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects. J. Clin. Endocrinol. Metab. 92, 1524-1529.
89. Holland, W. L., Brozinick, J. T., Wang, L. P., Hawkins, E. D., Sargent, K. M., Liu, Y., Narra, K., Hoehn, K. L., Knotts, T. A., Siesky, A., Nelson, D. H., Karathanasis, S. K., Fontenot, G. K., Birnbaum, M. J., and Summers, S. A. (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab. 5, 167-179.
90. Hajduch, E., Balendran, A., Batty, I. H., Litherland, G. J., Blair, A. S., Downes, C. P., and Hundal, H. S. (2001) Ceramide impairs the insulin-dependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 44, 173-183.
91. Chavez, J. A., and Summers, S. A. (2003) Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch. Biochem. Biophys. 419, 101-109.
92. Skovbro, M., Baranowski, M., Skov-Jensen, C., Flint, A., Dela, F., Gorski, J., and Helge, J. W. (2008) Human skeletal muscle ceramide content is not a major factor in muscle insulin sensitivity. Diabetologia 51, 1253-1260.
93. Cusi, K., Maezono, K., Osman, A., Pendergrass, M., Patti, M. E., Pratipanawatr, T., DeFronzo, R. A., Kahn, C. R., and Mandarino, L. J. (2000) Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle. J. Clin. Invest. 105, 311-320.
94. Timmers, S., Schrauwen, P., and de Vogel, J. (2008) Muscular diacylglycerol metabolism and insulin resistance. Physiol. Behav. 94, 242-251.
95. Turinsky, J., Bayly, B. P., and O'Sullivan, D. M. (1991) 1,2-Diacylglycerol and ceramide levels in rat liver and skeletal muscle in vivo. Am. J. Physiol. 261, E620-E627.
96. Itani, S. I., Pories, W. J., Macdonald, K. G., and Dohm, G. L. (2001) Increased protein kinase C theta in skeletal muscle of diabetic patients. Metabolism 50, 553-557.
97. Sebastian, D., Herrero, L., Serra, D., Asins, G., and Hegardt, F. G. (2007) CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance. Am. J. Physiol. Endocrinol. Metab. 292, E677-E686.
98. Bruce, C. R., Thrush, A. B., Mertz, V. A., Bezaire, V., Chabowski, A., Heigenhauser, G. J., and Dyck, D. J. (2006) Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content. Am. J. Physiol. Endocrinol. Metab. 291, E99-E107.
99. Dube, J. J., Amati, F., Stefanovic-Racic, M., Toledo, F. G., Sauers, S. E., and Goodpaster, B. H. (2008) Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited. Am. J. Physiol. Endocrinol. Metab. 294, E882-E888.